Supplementary Table S1 from Combination of the MTA-Cooperative PRMT5 Inhibitor BMS-986504 and KRAS Inhibitors Is an Effective Treatment Strategy for MTAP-Deleted KRAS-Mutant Pancreatic Cancer
收藏数据链接：
官方服务：
资源简介：
Supplementary Table S1 shows characterization of PDX models
创建时间：
2025-09-15
